November 18th, 2020 The Office of Research Integrity and Compliance is proud to release the 2019-2020 ORIC Annual Report. In here, you’ll find information on new ORIC updates, department highlights, new resources and training, and a letter from Dr. Erin Rothwell, Associate Vice President for Research. We hope you enjoy the annual report and find useful resources […]
Read MoreSIRB Site-Control Review Instructions Guidance ⏴back to Board Member Guidance Board Member Guidance Series SIRB Site-Control Review Instructions Version: November 17, 2020 Guidance As a board reviewer, you may be asked to review an application for a Single IRB (SIRB) study that the site-control model. These instructions are intended to help board members navigate ERICA […]
Read MoreOctober 20th, 2020 The university has recently moved from a COVID-19 Color Phase Guideline (red, orange, yellow, and green) to the State Governor’s new COVID-19 Transmission Index. Our level of transmission is currently at “HIGH”. The new transmission index has not changed allowable research activities on campus. We are still currently under “Limited Research Activities Status”. As a […]
Read MoreWriting a Review Summary – Facilitated Review of Community Consultation Plans for Studies Using an Exception from Informed Consent (EFIC) Introduction Guidance Documents and References ⏴back to Board Member Guidance Board Member Guidance Series Writing a Review Summary – Facilitated Review of Community Consultation Plans for Studies Using an Exception from Informed Consent (EFIC) Version: […]
Read MoreConsent During the COVID-19 Public Health Emergency Guidance Documents and References Points to Consider ⏴back to Guidance Series Consent During the COVID-19 Public Health Emergency Version: September 22, 2020 Guidance During the COVID-19 public health emergency, the IRB realizes that investigators must plan for adjustments to the consent process and documentation of consent. This guidance […]
Read MoreResearch Design Introduction Guidance Documents and References ⏴back to Guidance Series Research Design Version: September 10, 2020 Introduction “It is not unusual for institutional review board (IRB) members, institutional officials, and researchers to debate the role of the IRB in evaluating study design or other aspects that affect the fundamental quality of the science of […]
Read MorePlacebo Comparators Guidance Points to Consider ⏴back to Guidance Series Placebo Comparators Version: September 4, 2020 Guidance A protocol that involves removing participants from the standard medication for their disease or condition, and randomizing them to receive either an investigational agent or a placebo, may raise issues of participant safety. If some participants will receive […]
Read MoreFor critical updates affecting the University of Utah research community, please visit the Vice President for Research website: RESEARCH COMMUNITY UPDATES ON CORONAVIRUS March 12, 2020 The University of Utah IRB is heeding current guidelines from University leaders in response to the COVID-19 outbreak. This email is to provide the research community with information regarding […]
Read MoreMarch 12th, 2020 The University of Utah IRB is heeding current guidelines from University leaders in response to the COVID-19 outbreak. This email is to provide the research community with information regarding the review and conduct of human subject research during this time. The University of Utah IRB will be fully operational. There will be […]
Read MoreFebruary 24th, 2020 The ERICA online system was updated over the weekend. New features include: The “Jump To” menu has been moved to a left side floating menu, and will now only show pages that are considered “in-path”, or pages you need to complete for your particular application. Navigation buttons have been relocated. “Hide/Show Errors” […]
Read More